Management of Bullous Pemphigoid |
Conferences
eMediNexus Coverage from: 
Management of Bullous Pemphigoid
Dr Muralidhar Rajagopalan, Chennai,  21 January 2019
Coronavirus Live Count Map India

remove_red_eye 681 Views
COVID-19 Vaccine Updates

Coronavirus Protocols

#Dermatology

0 Read Comments                

Bullous pemphigoid: Localized/limited disease with mild activity.First choice: Super potent topical corticosteroids; in mild disease, on whole body except the face. In localized disease, on lesions only.Second choice: Oral corticosteroids (validated for prednisone); tetracycline + nicotinamide (nonvalidated); dapsone, sulfonamides (nonvalidated) and topical immunomodulation (e.g., tacrolimus) (nonvalidated).Third choice: Gaining more acceptance higher up in the ladder now - Combination with...
To read the complete article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now